Healthcare Industry Rapidly Moving Towards Nanotechnology for Diagnostics and Treatment, According to BCC Research
June 02, 2015
Wellesley, Mass., June 2, 2015 – With a growing demand for disposable medical devices that are safe and therefore cost-effective to use, disposable medical sensors have witnessed a surge in demand.BCC Research reveals in its new report that manufacturers, in an attempt to cater to the changing dynamics of the market, are shifting their focus towards developing disposable medical sensors.
The global disposable medical sensors market was valued at $3.8 billion in 2013 and is expected to grow at a compound annual growth rate (CAGR) of 10.2% during the forecast period, to reach an estimated value of $6.8 billion in 2019. Biosensors dominated the disposable sensor market in terms of revenue share. Increasing demand for diagnostic and monitoring devices such as cardiac pacemakers and blood glucose monitors are the key drivers of this segment.
A growing geriatric population coupled with spreading prevalence of target diseases pertaining to cardiovascular, audiology and urology systems are the most significant growth drivers of the disposable medical sensors market. In addition, rising usage rates of insulin and infusion pumps due to pervasive levels of diabetes is predicted to drive market growth further.
“The healthcare industry is rapidly moving towards miniaturization of equipment and use of nanotechnology for diagnostics and treatment. In keeping with this trend, manufacturers are focusing on producing MEMS (MicroElectroMechanical Systems),” says BCC Research analyst Vijay Laxmi. “Growing demand for minimally invasive surgeries and the presence of high unmet medical needs in emerging Latin American and Asia-Pacific economies are responsible for the growth of the market and also present significant opportunities for the disposable sensors.”
Disposable Medical Sensors: Technologies and Global Markets (HLC182A) discusses the global disposable medical sensors market in terms of growth, size and opportunities not only with regard to different products, but also regionally. The report includes forecasted trends and revenue through 2019.

![]()
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Disposable Medical Sensors: Technologies and Global Markets( HLC182A )
Publish Date: May 2015
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- Chronic Kidney Disease: Global Markets and Technologies
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development